Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2012; 18(42): 6134-6140
Published online Nov 14, 2012. doi: 10.3748/wjg.v18.i42.6134
Figure 1
Figure 1 The median progression-free survival (A) and overall survival (B) were longer in transcatheter arterial chemoembolization group than in control group (P = 0. 0001). TACE: Transcatheter arterial chemoembolization.